Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ)
CNY 13.18
(1.07%)
CNY 13.18
(1.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.17 Billion CNY | -0.59% |
| 2022 | 2.19 Billion CNY | 38.85% |
| 2021 | 1.57 Billion CNY | -8.99% |
| 2020 | 1.73 Billion CNY | -9.44% |
| 2019 | 1.91 Billion CNY | 34.97% |
| 2018 | 1.41 Billion CNY | 51.14% |
| 2017 | 938.43 Million CNY | 8.59% |
| 2016 | 864.22 Million CNY | 27.21% |
| 2015 | 679.39 Million CNY | 1.99% |
| 2014 | 666.12 Million CNY | 31.47% |
| 2013 | 506.65 Million CNY | -4.12% |
| 2012 | 528.39 Million CNY | 23.92% |
| 2011 | 426.39 Million CNY | -32.21% |
| 2010 | 629.02 Million CNY | 3.11% |
| 2009 | 610.05 Million CNY | -6.13% |
| 2008 | 649.89 Million CNY | -9.26% |
| 2007 | 716.17 Million CNY | 49.76% |
| 2006 | 478.23 Million CNY | 71.24% |
| 2005 | 279.27 Million CNY | 54.2% |
| 2004 | 181.1 Million CNY | 6.31% |
| 2003 | 170.36 Million CNY | 42.74% |
| 2002 | 119.35 Million CNY | 6.73% |
| 2001 | 111.82 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.72 Billion CNY | 8.47% |
| 2024 Q2 | 2.51 Billion CNY | -4.02% |
| 2024 Q1 | 2.61 Billion CNY | 20.12% |
| 2023 FY | 2.17 Billion CNY | -0.59% |
| 2023 Q2 | 2.33 Billion CNY | 4.49% |
| 2023 Q3 | 2.23 Billion CNY | -4.15% |
| 2023 Q1 | 2.23 Billion CNY | 1.81% |
| 2023 Q4 | 2.17 Billion CNY | -2.52% |
| 2022 Q2 | 1.89 Billion CNY | 13.89% |
| 2022 Q1 | 1.66 Billion CNY | 5.28% |
| 2022 FY | 2.19 Billion CNY | 38.85% |
| 2022 Q4 | 2.19 Billion CNY | 8.34% |
| 2022 Q3 | 2.02 Billion CNY | 6.88% |
| 2021 Q4 | 1.57 Billion CNY | 5.7% |
| 2021 FY | 1.57 Billion CNY | -8.99% |
| 2021 Q1 | 1.52 Billion CNY | -12.31% |
| 2021 Q2 | 1.51 Billion CNY | -0.54% |
| 2021 Q3 | 1.49 Billion CNY | -1.28% |
| 2020 Q2 | 1.93 Billion CNY | -8.05% |
| 2020 FY | 1.73 Billion CNY | -9.44% |
| 2020 Q1 | 2.1 Billion CNY | 9.96% |
| 2020 Q4 | 1.73 Billion CNY | -4.42% |
| 2020 Q3 | 1.81 Billion CNY | -6.29% |
| 2019 FY | 1.91 Billion CNY | 34.97% |
| 2019 Q4 | 1.91 Billion CNY | 11.72% |
| 2019 Q1 | 1.65 Billion CNY | 16.4% |
| 2019 Q2 | 1.69 Billion CNY | 2.48% |
| 2019 Q3 | 1.71 Billion CNY | 1.28% |
| 2018 Q1 | 970.08 Million CNY | 3.37% |
| 2018 FY | 1.41 Billion CNY | 51.14% |
| 2018 Q3 | 1.28 Billion CNY | 29.62% |
| 2018 Q4 | 1.41 Billion CNY | 10.1% |
| 2018 Q2 | 993.84 Million CNY | 2.45% |
| 2017 Q1 | 866.36 Million CNY | 0.25% |
| 2017 Q4 | 938.43 Million CNY | 21.82% |
| 2017 FY | 938.43 Million CNY | 8.59% |
| 2017 Q3 | 770.32 Million CNY | -11.82% |
| 2017 Q2 | 873.56 Million CNY | 0.83% |
| 2016 FY | 864.22 Million CNY | 27.21% |
| 2016 Q3 | 697.63 Million CNY | -6.23% |
| 2016 Q2 | 744 Million CNY | -2.58% |
| 2016 Q1 | 763.7 Million CNY | 12.41% |
| 2016 Q4 | 864.22 Million CNY | 23.88% |
| 2015 Q3 | 626.67 Million CNY | 12.14% |
| 2015 Q4 | 679.39 Million CNY | 8.41% |
| 2015 FY | 679.39 Million CNY | 1.99% |
| 2015 Q1 | 704.38 Million CNY | 5.74% |
| 2015 Q2 | 558.82 Million CNY | -20.67% |
| 2014 Q4 | 666.12 Million CNY | 30.46% |
| 2014 Q2 | 485.74 Million CNY | -10.18% |
| 2014 Q1 | 540.81 Million CNY | 6.74% |
| 2014 FY | 666.12 Million CNY | 31.47% |
| 2014 Q3 | 510.58 Million CNY | 5.11% |
| 2013 Q1 | 581.81 Million CNY | 10.11% |
| 2013 Q2 | 655.6 Million CNY | 12.68% |
| 2013 Q3 | 481.21 Million CNY | -26.6% |
| 2013 Q4 | 506.65 Million CNY | 5.29% |
| 2013 FY | 506.65 Million CNY | -4.12% |
| 2012 Q3 | 498.66 Million CNY | 5.78% |
| 2012 Q1 | 425.44 Million CNY | -0.22% |
| 2012 FY | 528.39 Million CNY | 23.92% |
| 2012 Q4 | 528.39 Million CNY | 5.96% |
| 2012 Q2 | 471.43 Million CNY | 10.81% |
| 2011 Q3 | 616.86 Million CNY | -4.76% |
| 2011 Q1 | 625.04 Million CNY | -0.63% |
| 2011 FY | 426.39 Million CNY | -32.21% |
| 2011 Q2 | 647.71 Million CNY | 3.63% |
| 2011 Q4 | 426.39 Million CNY | -30.88% |
| 2010 Q1 | 544.47 Million CNY | -10.75% |
| 2010 FY | 629.02 Million CNY | 3.11% |
| 2010 Q4 | 629.02 Million CNY | 0.84% |
| 2010 Q3 | 623.79 Million CNY | 4.6% |
| 2010 Q2 | 596.38 Million CNY | 9.53% |
| 2009 Q2 | 739.32 Million CNY | 6.76% |
| 2009 Q3 | 704.64 Million CNY | -4.69% |
| 2009 Q4 | 610.05 Million CNY | -13.42% |
| 2009 FY | 610.05 Million CNY | -6.13% |
| 2009 Q1 | 692.53 Million CNY | 6.56% |
| 2008 Q2 | 801.25 Million CNY | 7.27% |
| 2008 Q1 | 746.94 Million CNY | 4.3% |
| 2008 FY | 649.89 Million CNY | -9.26% |
| 2008 Q4 | 649.89 Million CNY | -12.35% |
| 2008 Q3 | 741.43 Million CNY | -7.47% |
| 2007 Q4 | 716.17 Million CNY | 4.7% |
| 2007 Q3 | 684.03 Million CNY | 7.99% |
| 2007 Q2 | 633.41 Million CNY | 2.71% |
| 2007 Q1 | 616.7 Million CNY | 28.96% |
| 2007 FY | 716.17 Million CNY | 49.76% |
| 2006 Q1 | 376.33 Million CNY | 34.76% |
| 2006 Q3 | 463.47 Million CNY | 11.39% |
| 2006 Q2 | 416.08 Million CNY | 10.56% |
| 2006 Q4 | 478.23 Million CNY | 3.18% |
| 2006 FY | 478.23 Million CNY | 71.24% |
| 2005 Q4 | 279.27 Million CNY | 29.35% |
| 2005 Q3 | 215.89 Million CNY | -0.2% |
| 2005 Q2 | 216.34 Million CNY | 1.98% |
| 2005 FY | 279.27 Million CNY | 54.2% |
| 2005 Q1 | 212.13 Million CNY | 17.13% |
| 2004 Q4 | 181.1 Million CNY | 2.75% |
| 2004 FY | 181.1 Million CNY | 6.31% |
| 2004 Q2 | 216.18 Million CNY | 0.0% |
| 2004 Q3 | 176.26 Million CNY | -18.46% |
| 2003 Q4 | 170.36 Million CNY | 0.0% |
| 2003 FY | 170.36 Million CNY | 42.74% |
| 2002 FY | 119.35 Million CNY | 6.73% |
| 2001 FY | 111.82 Million CNY | 0.0% |